CDKN2A and cancer: The expression/activation of Arf1 and its GEFs are often associated with cell proliferation, migration, and tumor-cell invasion in various cancers [10], and Arf1 and Arf/GEF complexes have thus been proposed as valuable candidate targets in cancer therapy [11,12,13].